Encorafenib + binimetinib: a profile of their combined use in treating BRAF-mutated unresectable or metastatic melanoma Katherine A. Lyseng-Williamson Adis Drug Q&A 18 February 2019 Pages: 151 - 159
Ivosidenib in relapsed or refractory acute myeloid leukemia: a profile of its use in the USA Emma H. McCaffertyKatherine A. Lyseng-Williamson Adis Drug Q&A Open access 18 February 2019 Pages: 160 - 166
Manage endometriosis-related pain with hormonal suppression therapies Adis Medical Writers Disease Management 18 January 2019 Pages: 167 - 170
Consider lithium for the treatment of bipolar disorder in paediatric patients Adis Medical Writers Disease Management 27 February 2019 Pages: 171 - 175
Consider using selected antiepileptics to reduce the frequency of various types of headaches Adis Medical Writers Disease Management 19 January 2019 Pages: 176 - 179
First reports of adverse drug reactions Drug Reactions and Interactions 14 February 2019 Pages: 180 - 180
Tamsulosin in urology: beyond benign prostatic hyperplasia G. G. Laxman PrabhuHiren PrajapatiAmit B. Jain Review Article 19 February 2019 Pages: 181 - 184
Physician perception of patients’ requests for medications in Yemen Mohsen Ali MurshidZurina Mohaidin Original Research Article 30 January 2019 Pages: 185 - 191
Management of atherogenic dyslipidemia according to current treatment guidelines: DESPEGA study in real clinical practice Jesús Núñez-CortésPatricia Rodríguez-FortúnezMaria Luisa Orera-Peña Original Research Article 31 January 2019 Pages: 192 - 199
Correction to: “Correction to: Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use” Katherine A. Lyseng-Williamson Correction Open access 21 February 2019 Pages: 200 - 200
